News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

Unusual Presentation of Ectopic Extramammary Paget Disease
MDedge Dermatology
Pemphigus remission rate tops 80% with rituximab
MDedge Dermatology
FDA approves rituximab for treating pemphigus vulgaris
MDedge Dermatology
Extramammary Paget Disease: Making the Correct Diagnosis
MDedge Dermatology
Surgical Procedures for Hidradenitis Suppurativa
MDedge Dermatology
Oral drug seen preventing angioedema attacks
MDedge Dermatology
Study offers snapshot of esophageal strictures in EB patients
MDedge Dermatology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Dermatology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Dermatology
RFPs Available for the Study of Three Rare Diseases
MDedge Dermatology